FL Group is the first Italian company to be granted government approval for medical cannabis flower distribution. This month, the products should be available in pharmacies all over Italy. Â
Denise Faltischek (chief strategy officer, head of International, Tilray Brands) said that this “milestone highlights the crucial role of medical cannabis in supporting the well-being and health of those who need it.”Â
Faltischek stated, “We’re proud to be expanding our portfolio of medical cannabis in Italy by introducing our Tilray Medical EU-GMP-certified medical cannabis products which meet the highest standards for patient care.” “We extend our gratitude to the Ministero della Salute (Italian Ministry of Health) for their trust in Tilray Medical and for providing the necessary regulatory framework to ensure access to safe, consistent and reliable cannabinoid-based therapies. We are working together to advance health care, patient wellbeing and innovation. — Faltischek in a Press ReleaseÂ
Tilray Medical has three products approved: Tilray THC 25 %, Tilray THC 18%, and Tilray THC 9 / CBD 9 %.Â
Italy legalized medicinal cannabis in 2013, and at first relied upon imported products. Later, however, local cultivation was entrusted to the Italian Army, who were tasked by the Military Pharmaceutical Plant of Florence. criticized For producing flowers of low quality. Â
Receive daily updates on the cannabis industry. Subscribe to our Newsletter
MEDACAN24 can only be made possible with the help of our partners.